STAT
APRIL 16, 2025
In a single day, 10,000 federal workers at the Centers for Disease Control and Prevention and the Food and Drug Administration were laid off, including 90% or more of those at the CDC’s National Institute for Occupational Safety and Health (NIOSH). The office may be little-known outside of public health circles, but it is of critical importance.
PharmaVoice
APRIL 16, 2025
Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 16, 2025
A federal judge has given the go-ahead for a class-action lawsuit that could radically expand Americans’ access to lifesaving addiction medications. The perhaps surprising defendant: The Salvation Army, the Christian charity known more for its thrift stores than for its nationwide network of addiction treatment facilities.
Express Pharma
APRIL 16, 2025
The Ministry of Health and Family Welfare, Government of India, has issued a notification restricting the manufacture, sale and distribution of all formulations of the fixed dose combination (FDC) of Chlorpheniramine Maleate and Phenylephrine Hydrochloride for use in children below four years of age. The notification, dated 15 April 2025, was issued under Section 26A of the Drugs and Cosmetics Act, 1940 (23 of 1940), citing the potential risk of using the said FDC in children under four and the
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
STAT
APRIL 16, 2025
Welcome to Lab Dish , a new First Opinion column on regenerative medicine from Paul Knoepfler. I’m upbeat about cell therapy development for Parkinson’s disease, but it has been a marathon. Now two new clinical trial papers published Wednesday in Nature on stem cell-based therapies for Parkinson’s are another step forward. However, they also highlight remaining challenges and dilemmas, including the optimal doses of cells, the extent of engraftment, and whether to use alloge
National Association of Boards of Pharmacy
APRIL 16, 2025
At NABP, we offer pharmacist examinations like the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) to assess a pharmacists competency to practice while protecting the public health. In our last blog post, we discussed the development and the recent improvements that have been made to the MPJE and its purpose: to evaluate candidates understanding and application of federal and state-specific laws and regulations.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
APRIL 16, 2025
Parexel, a global clinical research organisation (CRO) offering end-to-end Phase I to IV clinical development services, has announced the appointment of Charlotte Moser, MD, PhD, MBA, as its new Chief Medical Officer. The company stated that this leadership change aligns with its focus on advancing global clinical research through strategic drug development and therapeutic expertise.
STAT
APRIL 16, 2025
LONDON — Five years after Covid-19 triggered national lockdowns, economic uncertainty and killed millions , the World Health Organization’s member countries agreed on a draft “pandemic treaty” that sets guidelines for how the international community might confront the next global health crisis.
Express Pharma
APRIL 16, 2025
Shilpa Medicare has announced that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has approved its Investigational New Drug (IND) Nor Ursodeoxycholic Acid (Nor UDCA) Tablets 500 mg. The committee has also recommended granting marketing authorisation for the treatment of non-alcoholic fatty liver disease (NAFLD).
STAT
APRIL 16, 2025
Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. Isaac “Zak” Kohane is the chair of biomedical informatics at Harvard Medical School. He’s uniquely situated for the explosion of AI in health care, having a Ph.D. in computer science as well as an M.D.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Express Pharma
APRIL 16, 2025
Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the upcoming launch of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulphate and Amphetamine Sulphate Tabletsalso referred to as Mixed Salts of a Single Entity Amphetamine Productin strengths of 5 mg, 10 mg, 15 mg, 20 mg and 30 mg. Glenmark confirmed that its product is bioequivalent and therapeutically equivalent to the reference listed drug, Adderall Tablets, marketed in the same strengths by Teva Womens Heal
Pharmafile
APRIL 16, 2025
Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) rates of newly diagnosed multiple myeloma (NDMM) than conventional bortezomib, lenalidomide and dexamethasone (VRd) chemotherapy. The treatment could help NDMM patients approach normal expectancy without their disease progressing, with PFS projected to be 17 years. […] The post Johnson & Johnson announces successful
Express Pharma
APRIL 16, 2025
Sun Pharmaceutical Industries has appointed Shaik Barak Tulla as its new Senior Vice President. The appointment strengthens Sun Pharmas senior leadership as it continues to expand operations across global markets. Shaik brings over 25 years of experience in the pharmaceutical sector. Before joining Sun Pharma, he served as Senior Vice President and Chief Commercial Head Acute Cluster at Cipla.
Pharma Marketing Network
APRIL 16, 2025
Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
ID Stewardship
APRIL 16, 2025
In this article a current third year pharmacy student discusses pharmacy student study strategies to maximize learning in 2025 and beyond. Authored By:Fabian Quiroga, Pharm.D. Candidate 2026 Article posted 16 April 2025 No one really warns you about just how much content you will encounterin pharmacy school – until you are in it. Whether it is a single week, an entire module, or the full school year, the amount of material can feel overwhelming.
Drug Patent Watch
APRIL 16, 2025
"Patent Expiration: The Secret to Unlocking $100 Billion in Pharmaceutical Value Did you know that patent expirations in the pharmaceutical industry are projected to unlock over $100 billion in new business opportunities? At Drug Patent Watch, we've analyzed the latest data to reveal the top 5 therapeutic areas poised for disruption. From oncology to cardiovascular disease, we've identified the key trends and insights you need to know to make informed investment decisions.
ID Stewardship
APRIL 16, 2025
In this article two infectious diseases pharmacists discuss five things to know about interpreting MRSA naresswab results Authored By: Hunter Rondeau, Pharm.D., BCIDP & Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 16 April 2025 The methicillin-resistant Staphylococcus aureus (MRSA) naresswab (also referred to as a MRSA nasal swab) is a valuable tool for infection control programs, helping to identify which patients are colonized with MRSA and in turn may be at risk for MRSA inf
Pharmafile
APRIL 16, 2025
Astraveus has announced a series of senior appointments as it advances towards the launch of its Lakhesys Benchtop Cell Factory, an innovative microfluidic system for cell therapy manufacturing. Jean-Paul Mangeolle (pictured left) joins as chairman of the board of directors, bringing more than 35 years of life sciences leadership, including leadership roles at Millipore, Danaher […] The post Astraveus expands leadership team ahead of Lakhesys launch appeared first on Pharmafile.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
ID Stewardship
APRIL 16, 2025
In this article an infectious diseases pharmacist discusses someof many learning tidbitsfrom ESCMID Global 2025, the largest international meeting of clinical microbiologists and infectious diseases specialists. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 16 April 2025 This year the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) held their main annual conference called ESCMID Global in Vienna, Austria.
Pharma Times
APRIL 16, 2025
European Commission grants authorisation for Eisai and Biogen therapy
The Pharmacist
APRIL 16, 2025
Healthcare professionals should be trained in digital antimicrobial stewardship (AMS) technologies, new guidance from NHS England has said. This could include digital systems that capture AMS metrics and performance, as well as decision support tools and potentially artificial intelligence. This comes as 20% of clinicians surveyed by NHS England said they spent more than five […] The post New NHS vision for antimicrobial stewardship focuses on digital solutions appeared first on The Pharma
Pharma Marketing Network
APRIL 16, 2025
If your brand still views content as a checkbox for SEO or a static digital asset, you’re already falling behind. In the ever-evolving healthcare landscape, especially in 2025, content marketing strategies have moved from optional to mission-critical for pharma brands. But not just any content will do. Today, successful campaigns are dynamic, identity-driven, omnichannel, and personalized.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
European Pharmaceutical Review
APRIL 16, 2025
The European Commission (EC) has granted a marketing authorization for Leqembi (lecanemab) as the first therapy in the EU targeting an underlying cause of Alzheimers. Eisai Co., Ltd. and Biogen Inc.s amyloid-beta (A) monoclonal antibody is indicated for adults with mild cognitive impairment and mild dementia due to Alzheimers who are apolipoprotein E 4 (ApoE 4*) non-carriers or heterozygotes with confirmed amyloid pathology.
BioPharma Dive
APRIL 16, 2025
Two studies published in Nature found stem cell-derived products can not only be safely transplanted into the brain, but also show promising — albeit unproven — signs of efficacy.
The Pharmacist
APRIL 16, 2025
Pharmacists working in general practice write just 1.5% of fit notes, despite reforms introduced in 2022 that allow them to do so. The majority (90%) of fit notes are issued by GPs, and have been since the reforms were introduced. Nurses issue just over 7% of fit notes with practice based pharmacists doing around 1.5%. […] The post Pharmacists write just 1.5% of fit notes since reforms introduced appeared first on The Pharmacist.
FDA Law Blog: Biosimilars
APRIL 16, 2025
By Andrew J. Hull & JP Ellison & John W.M. Claud Hyman, Phelps & McNamara, P.C. is hosting a free webinar on recent and forward-looking enforcement under the Federal Food, Drug & Cosmetic Act on Thursday, May 1, 2025, from 12:00 p.m. to 1:30 p.m. (ET) (register here ). Join us as HPMs Anne Walsh moderates a panel discussion with three former DOJ attorneys who all litigated extensively under the FDCA.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
APRIL 16, 2025
Pharmacists working in general practice write just 1.5% of fit notes, despite reforms introduced in 2022 that allow them to do so. The majority (90%) of fit notes are issued by GPs, and have been since the reforms were introduced. Nurses issue just over 7% of fit notes with practice based pharmacists doing around 1.5%. […] The post Pharmacists write just 1.5% of fit notes since reforms introduced appeared first on The Pharmacist.
pharmaphorum
APRIL 16, 2025
The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.
BioPharma Dive
APRIL 16, 2025
The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in glycosylation.
pharmaphorum
APRIL 16, 2025
Click Therapeutics' digital therapeutic (DTx) for migraine prevention has been cleared by the FDA, becoming the first treatment of its type in the US.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Expert insights. Personalized for you.
350 
Let's personalize your content